What does DR. LEEN VANKEIRSBILCK do?

DR. LEEN VANKEIRSBILCK is a general practice in Wevelgem. Private Limited, started on 23 August 2017, 1 establishment.

What is the address of DR. LEEN VANKEIRSBILCK?

The registered office of DR. LEEN VANKEIRSBILCK is located at Meerlaanstraat 29 box B, 8560 Wevelgem.

Is DR. LEEN VANKEIRSBILCK still active?

Yes. According to the CBE (26 September 2026) DR. LEEN VANKEIRSBILCK is active, legal situation “Normale toestand”, started on 23 August 2017.

Is DR. LEEN VANKEIRSBILCK registered on Peppol?

Yes, DR. LEEN VANKEIRSBILCK is registered on the Peppol network with ID 0208:0679970889.

What is the enterprise number of DR. LEEN VANKEIRSBILCK?

The enterprise number of DR. LEEN VANKEIRSBILCK is BE0679970889.

When was DR. LEEN VANKEIRSBILCK founded?

DR. LEEN VANKEIRSBILCK was founded on 23 August 2017.

Who are the directors of DR. LEEN VANKEIRSBILCK?

According to the 2025 annual accounts, the directors of DR. LEEN VANKEIRSBILCK are: Leen Vankeirsbilck.

Is DR. LEEN VANKEIRSBILCK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 August 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. LEEN VANKEIRSBILCK make in 2025?

DR. LEEN VANKEIRSBILCK posted a profit after taxes of € 99,634 in financial year 2025.

What is the revenue of DR. LEEN VANKEIRSBILCK?

As a small company, DR. LEEN VANKEIRSBILCK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 146,729.

DR. LEEN VANKEIRSBILCK (Private Limited) - Wevelgem

Dossier DR. LEEN VANKEIRSBILCK, printed on 26 September 2026 from databakkes.be/en/0679970889/dr-leen-vankeirsbilck. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR. LEEN VANKEIRSBILCK from Wevelgem, company number BE0679970889, closed financial year 2025 with a result of € 99,634 after tax. For that financial year DR. LEEN VANKEIRSBILCK recorded a gross margin of € 146,729 and equity of € 139,011. Compared with financial year 2024, the result moved from € 94,690 to € 99,634. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Healthy

€ 139,011

▼ 41% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 99,634

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 98,521

▲ 24% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 195,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 17,542

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,449

▲ 184% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,599

▼ 3% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 130,450 Gross margin 2022: € 130,450 First fiscal year in the series	€ 145,230 Gross margin 2023: € 145,230 ▲ 11% vs 2022 (€ 130,450) Favourable step	€ 140,654 Gross margin 2024: € 140,654 ▼ 3% vs 2023 (€ 145,230) Unfavourable step	€ 146,729 Gross margin 2025: € 146,729 ▲ 4% vs 2024 (€ 140,654) Favourable step	▲ 4%
Profit after taxes	€ 84,540 Profit after taxes 2022: € 84,540 First fiscal year in the series	€ 98,242 Profit after taxes 2023: € 98,242 ▲ 16% vs 2022 (€ 84,540) Favourable step	€ 94,690 Profit after taxes 2024: € 94,690 ▼ 4% vs 2023 (€ 98,242) Unfavourable step	€ 99,634 Profit after taxes 2025: € 99,634 ▲ 5% vs 2024 (€ 94,690) Favourable step	▲ 5%
Equity	€ 211,444 Equity 2022: € 211,444 First fiscal year in the series	€ 239,687 Equity 2023: € 239,687 ▲ 13% vs 2022 (€ 211,444) Favourable step	€ 234,377 Equity 2024: € 234,377 ▼ 2% vs 2023 (€ 239,687) Unfavourable step	€ 139,011 Equity 2025: € 139,011 ▼ 41% vs 2024 (€ 234,377) Unfavourable step	▼ 41%
Total debts	€ 105,835 Total debts 2022: € 105,835 First fiscal year in the series	€ 40,938 Total debts 2023: € 40,938 ▼ 61% vs 2022 (€ 105,835) Favourable step	€ 54,188 Total debts 2024: € 54,188 ▲ 32% vs 2023 (€ 40,938) Unfavourable step	€ 190,676 Total debts 2025: € 190,676 ▲ 252% vs 2024 (€ 54,188) Unfavourable step	▲ 252%
Cash	€ 214,110 Cash 2022: € 214,110 First fiscal year in the series	€ 90,548 Cash 2023: € 90,548 ▼ 58% vs 2022 (€ 214,110) Unfavourable step	€ 79,381 Cash 2024: € 79,381 ▼ 12% vs 2023 (€ 90,548) Unfavourable step	€ 98,521 Cash 2025: € 98,521 ▲ 24% vs 2024 (€ 79,381) Favourable step	▲ 24%
Retained profit	€ 192,844 Retained profit 2022: € 192,844 First fiscal year in the series	€ 221,087 Retained profit 2023: € 221,087 ▲ 15% vs 2022 (€ 192,844) Favourable step	€ 215,777 Retained profit 2024: € 215,777 ▼ 2% vs 2023 (€ 221,087) Unfavourable step	€ 120,411 Retained profit 2025: € 120,411 ▼ 44% vs 2024 (€ 215,777) Unfavourable step	▼ 44%
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 70,000 Dividend 2023: € 70,000 ▼ 30% vs 2022 (€ 100,000) Unchanged	€ 100,000 Dividend 2024: € 100,000 ▲ 43% vs 2023 (€ 70,000) Unchanged	€ 195,000 Dividend 2025: € 195,000 ▲ 95% vs 2024 (€ 100,000) Unchanged	▲ 95%
Balance sheet total	€ 317,280 Balance sheet total 2022: € 317,280 First fiscal year in the series	€ 280,624 Balance sheet total 2023: € 280,624 ▼ 12% vs 2022 (€ 317,280) Unchanged	€ 288,565 Balance sheet total 2024: € 288,565 ▲ 3% vs 2023 (€ 280,624) Unchanged	€ 329,687 Balance sheet total 2025: € 329,687 ▲ 14% vs 2024 (€ 288,565) Unchanged	▲ 14%

Key figures of DR. LEEN VANKEIRSBILCK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. LEEN VANKEIRSBILCK?

What happened at DR. LEEN VANKEIRSBILCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 99,634 (▲ 5% vs 2024). Source: NBB ↗
Aug 23, 2017 New establishment in Wevelgem. KBO
Aug 23, 2017 Start of the company according to the CBE. KBO

In short

From € 84,540 profit in 2022 to € 99,634 profit in 2025.

Paid € 107,558 in corporate taxes since 2022.

Best year ever: 2025, with € 99,634 profit.

Paid out € 465,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. LEEN VANKEIRSBILCK? We notify you, reason included.

Follow DR. LEEN VANKEIRSBILCK

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Leen Vankeirsbilck

DR. LEEN VANKEIRSBILCK

Behind DR. LEEN VANKEIRSBILCK is Leen Vankeirsbilck.

See the full network in the app

Directors

According to the 2025 annual accounts

Leen Vankeirsbilck

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Meerlaanstraat 29 box B

8560 Wevelgem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

De Huiszwaluw

€ 259,955 gross margin · 2025

Moorsele Events

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0679.970.889

VAT number

BE 0679.970.889

Registered office

Meerlaanstraat 29 bus B, 8560 Wevelgem

Names & denominations

DR. LEEN VANKEIRSBILCK · LEEN VANKEIRSBILCK

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 August 2017

Peppol

Active · Active since 31 Oct 2023

Activities · NACE

Activiteiten van huisartspraktijken

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗